Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 45

Results For "RIL"

1109 News Found

Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma
News | October 03, 2023

Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma

The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete


Solvay celebrates Medicine Nobel Prize winner Katalin Karikó
News | October 03, 2023

Solvay celebrates Medicine Nobel Prize winner Katalin Karikó

Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate


Doceree raises US$ 35 million in Series B Funding
News | September 29, 2023

Doceree raises US$ 35 million in Series B Funding

Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe


GeoVax secures multi-product license for ProBioGen's AGE1.CR.pIX suspension cell line
Drug Approval | September 27, 2023

GeoVax secures multi-product license for ProBioGen's AGE1.CR.pIX suspension cell line

The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types


Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India
News | September 23, 2023

Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India

Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health


Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
News | September 22, 2023

Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr

Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction


Jupiter Life Line Hospitals lists at 32.38% premium
News | September 20, 2023

Jupiter Life Line Hospitals lists at 32.38% premium

The market capitalization of the company stood at Rs. 7,000 crore +


Fortis Bannerghatta conducts Karnataka's first pediatric robot-assisted surgery
Healthcare | September 20, 2023

Fortis Bannerghatta conducts Karnataka's first pediatric robot-assisted surgery

The complexity of operating on a one-year-old are many with the organs being tiny, fragile


Remedi introduces best handheld X-ray solution to India
Medical Device | September 19, 2023

Remedi introduces best handheld X-ray solution to India

This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses


Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Drug Approval | September 19, 2023

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy